Research programme: mTOR inhibitors - Delos Pharmaceuticals
Alternative Names: BC 210; bPT-mTOR series; nPT-mTOR seriesLatest Information Update: 04 Nov 2017
Price :
$50 *
At a glance
- Originator Biotica Technology
- Developer Delos Pharmaceuticals
- Class Macrolides
- Mechanism of Action MTOR protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Unspecified